Plasma-fibrinogen and thromboemboli after myocardial infarction.
In 120 patients with myocardial infarction subsequent non-fatal thromboemboli occurred only in patients in whom plasma-fibrinogen had exceeded 750 mg/dl. It is suggested that patients at risk from thromboembolism after infarction can be identified by monitoring plasma-fibrinogen and that appropriate anticoagulation might reduce morbidity.
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D002940:Circadian Rhythm; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000032:analysis*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000150:complications / Q000201:enzymology; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology*; D013997:Time Factors
D005340:Fibrinogen; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase